Overview
Efficacy and Safety of Fosrenol in Treating Elevated Serum Phosphate Levels in Adults With End Stage Renal Disease
Status:
Completed
Completed
Trial end date:
2005-12-13
2005-12-13
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to test how well lanthanum carbonate reduces the pre-dialysis level of serum phosphorus in subjects undergoing dialysis due to end stage renal disease and to determine the patient and physician's satisfaction.Phase:
Phase 4Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Shire
Criteria
Inclusion Criteria:- Patients with ESRD who currently require treatment for hyperphosphatemia
Exclusion Criteria:
- Female patient who is pregnant or lactating
- Patient has used any investigational product within 30 days of screening